We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

Phase 3 trial of Biogen and UCB's dapirolizumab pegol shows significant improvement in lupus disease activity. Read more here ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

Biogen Idec Inc的股价已触及52周低点，交易价格为156.9美元，反映出这家生物技术公司正经历一段充满挑战的时期。过去一年，该公司股价下跌了31.68%，表明投资者存在重大担忧，市场压力较大。这一下滑发生在整个行业波动性较大的背景下，同时公司还面临着特定的障碍，包括竞争激烈的市场动态和产品管线的挫折。投资者正密切关注Biogen的战略举措，以重振增长并重获市场信心。 在其他近期新闻中 ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline systemic lupus erythematosus therapies in various stages of clinical ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...

Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its ...

CareMessage, the largest patient activation platform in the United States for underserved populations, today announced the launch of their AI Assistant, adding ethical AI tools to their market-leading ...

CVS Health® today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health.

RP-A501 reduced LV mass index by ≥10% in Danon disease patients, sustained up to 54 months. Median reductions in cardiac ...

Dividend announcements are not available.